Isoxsuprine hydrochloride in the horse: a review.
Abstract: Isoxsuprine hydrochloride has been suggested for use in horses for treatment of navicular syndrome and laminitis. The drug has been shown to be a beta-adrenoreceptor antagonist with beta-adrenoreceptor agonistic properties, with both characteristics contributing to vasodilation and uterine relaxation. In addition, the drug is capable of decreasing blood viscosity and platelet aggregation. Studies have shown i.v. isoxsuprine to have a plasma half-life of <3 h with a large apparent volume of distribution. Cardiovascular effects resolve rapidly following i.v. administration, but are absent with oral dosing. Oral bioavailability is 2.2% with a high first pass effect. Isoxsuprine has an apparent affinity for melanin that may contribute to extended renal excretion. Clinical trials appear to support the use of isoxsuprine for treatment of navicular disease. However, poor bioavailability, lack of cardiovascular effects following oral administration, superficial support in clinical trials, and new evidence regarding the pathogenesis of navicular syndrome indicate that the use of isoxsuprine for treatment of navicular syndrome or laminitis is questionable at best.
Publication Date: 2002-05-10 PubMed ID: 12000527DOI: 10.1046/j.1365-2885.2002.00386.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Review
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The article reviews the use and effectiveness of Isoxsuprine hydrochloride as a treatment for navicular syndrome and laminitis in horses. The authors conclude that despite some potentially beneficial properties, its effectiveness is questionable due to factors such as poor bioavailability and lack of cardiovascular effects with oral use.
Properties and Use of Isoxsuprine Hydrochloride
- The drug has a dual action, working as both a beta-adrenoreceptor antagonist and agonist. This causes vasodilation (expansion of blood vessels), uterine relaxation, and also reduces blood viscosity and platelet aggregation.
- Isoxsuprine has been suggested for the treatment of horse ailments like navicular syndrome and laminitis, both of which are conditions that affect the hooves and can cause significant pain and lameness.
Pharmacokinetic Properties of Isoxsuprine
- When administered intravenously (i.v.), the drug has a short plasma half-life of fewer than 3 hours. This means the quantity of the drug reduces by half in the bloodstream in less than 3 hours from administration.
- The cardiovascular effects of the drug diminish quickly after i.v. administration but are absent when taken orally.
- Oral bioavailability (the rate and amount at which the active ingredient or therapeutic effect of a drug becomes available) is low at just 2.2%.
- The drug has a high first pass effect, meaning a significant portion of the drug is metabolized before it reaches systemic circulation.
- Isoxsuprine shows an apparent affinity for melanin, which may contribute to its extended excretion via the kidneys.
Efficacy of Isoxsuprine
- Clinical trials seem to support the use of isoxsuprine for treating navicular disease, but the evidence is described as ‘superficial’.
- Due to its poor oral bioavailability, lack of cardiovascular effects following oral consumption, and new evidence about the development of navicular syndrome, the research raises questions about the efficacy and practicability of isoxsuprine for handling navicular syndrome or laminitis in horses.
- The researchers conclude that the use of this drug for such conditions is questionable.
Cite This Article
APA
Erkert RS, Macallister CG.
(2002).
Isoxsuprine hydrochloride in the horse: a review.
J Vet Pharmacol Ther, 25(2), 81-87.
https://doi.org/10.1046/j.1365-2885.2002.00386.x Publication
Researcher Affiliations
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater, OK 74078, USA.
MeSH Terms
- Administration, Oral
- Animals
- Biological Availability
- Foot Diseases / drug therapy
- Foot Diseases / veterinary
- Horse Diseases / drug therapy
- Horses / metabolism
- Infusions, Intravenous / veterinary
- Isoxsuprine / administration & dosage
- Isoxsuprine / pharmacokinetics
- Isoxsuprine / therapeutic use
- Lameness, Animal / drug therapy
- Osteitis / drug therapy
- Osteitis / veterinary
- Tarsal Bones / blood supply
- Vasodilator Agents / administration & dosage
- Vasodilator Agents / pharmacokinetics
- Vasodilator Agents / therapeutic use
Citations
This article has been cited 1 times.- Kretschy N, Teichmann M, Kopf S, Atanasov AG, Saiko P, Vonach C, Viola K, Giessrigl B, Huttary N, Raab I, Krieger S, Jäger W, Szekeres T, Nijman SM, Mikulits W, Dirsch VM, Dolznig H, Grusch M, Krupitza G. In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.. Br J Cancer 2013 Feb 19;108(3):570-8.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
